Virtual Screening for Identification of Dual Inhibitors against CDK4/6 and Aromatase Enzyme

CDK4/6 and aromatase are prominent targets for breast cancer drug discovery and are involved in abnormal cell proliferation and growth. Although aromatase inhibitors have proven to be effective (for example exemestane, anastrozole, letrozole), resistance to treatment eventually occurs through the ac...

Description complète

Détails bibliographiques

Auteurs principaux:	Tenzin Adon, Dhivya Shanmugarajan, Hissana Ather, Shaik Mohammad Asif Ansari, Umme Hani, SubbaRao V. Madhunapantula, Yogish Kumar Honnavalli
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2023-03-01
Collection:	Molecules
Sujets:	dual inhibitor CDK4/6 aromatase structure-based pharmacophore molecular docking MD simulations
Accès en ligne:	https://www.mdpi.com/1420-3049/28/6/2490
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!